糖尿病肾病
足细胞
内科学
内分泌学
肾功能
糖尿病
丙酮酸激酶
糖酵解
肾小球基底膜
巴基斯坦卢比
化学
肾病
医学
肾
新陈代谢
肾小球肾炎
蛋白尿
作者
Jialin Fu,Takanori Shinjo,Qian Li,Ronald St-Louis,Kyoungmin Park,Marc Gregory Yu,Hisashi Yokomizo,Fabrício Simão,Qian Huang,I‐Hsien Wu,George Liang King
出处
期刊:JCI insight
[American Society for Clinical Investigation]
日期:2022-02-08
卷期号:7 (5)
被引量:48
标识
DOI:10.1172/jci.insight.155260
摘要
Diabetic nephropathy (DN) arises from systemic and local changes in glucose metabolism and hemodynamics. We have reported that many glycolytic and mitochondrial enzymes, such as pyruvate kinase M2 (PKM2), were elevated in renal glomeruli of DN-protected patients with type 1 and type 2 diabetes. Here, mice with PKM2 overexpression specifically in podocytes (PPKM2Tg) were generated to uncover the renal protective function of PPKM2Tg as a potential therapeutic target that prevented elevated albumin/creatinine ratio (ACR), mesangial expansion, basement membrane thickness, and podocyte foot process effacement after 7 months of streptozotocin-induced (STZ-induced) diabetes. Furthermore, diabetes-induced impairments of glycolytic rate and mitochondrial function were normalized in diabetic PPKM2Tg glomeruli, in concordance with elevated Ppargc1a and Vegf expressions. Restored VEGF expression improved glomerular maximal mitochondrial function in diabetic PPKM2Tg and WT mice. Elevated VEGF levels were observed in the glomeruli of DN-protected patients with chronic type 1 diabetes and clinically correlated with estimated glomerular filtration (GFR) - but not glycemic control. Mechanistically, the preservations of mitochondrial function and VEGF expression were dependent on tetrameric structure and enzymatic activities of PKM2 in podocytes. These findings demonstrate that PKM2 structure and enzymatic activation in podocytes can preserve the entire glomerular mitochondrial function against toxicity of hyperglycemia via paracrine factors such as VEGF and prevent DN progression.
科研通智能强力驱动
Strongly Powered by AbleSci AI